Körtvelyessy Peter, Huchtemann Tessa, Heinze Hans-Jochen, Bittner Daniel M
Department of Neurology, University Hospital Magdeburg, 39210 Magdeburg, Germany.
German Center for Neurodegenerative Diseases, 39120 Magdeburg, Germany.
Int J Mol Sci. 2017 Feb 24;18(3):490. doi: 10.3390/ijms18030490.
The current knowledge about neuroprotective mechanisms in humans after status epilepticus is scarce. One reason is the difficulty to measure possible mediators of these neuroprotective mechanisms. The dawn of microRNA detection in the cerebrospinal fluid (CSF) and the recent advancements in measuring proteins in the CSF such as progranulin, which is, e.g., responsible for neurite outgrowth and limiting exceeding neuroinflammatory responses, have given us new insights into putative neuroprotective mechanisms following status epilepticus. This should complement the animal data. In this review, we cover what is known about the role of progranulin as well as the links between microRNA changes and the progranulin pathway following status epilepticus in humans and animals hypothesizing neuroprotective and neurorehabilitative effects. Progranulin has also been found to feature prominently in the neuroprotective processes under hypoxic conditions and initiating neurorehabilitative processes. These properties may be used therapeutically, e.g., through drugs that raise the progranulin levels and therefore the cerebral progranulin levels as well with the goal of improving the outcome after status epilepticus.
目前关于癫痫持续状态后人体神经保护机制的知识匮乏。原因之一是难以测量这些神经保护机制的潜在介质。脑脊液(CSF)中微小RNA检测的出现以及CSF中蛋白质测量的最新进展,如原颗粒蛋白(例如,其负责神经突生长并限制过度的神经炎症反应),使我们对癫痫持续状态后假定的神经保护机制有了新的认识。这应该补充动物数据。在这篇综述中,我们涵盖了已知的原颗粒蛋白的作用以及癫痫持续状态后人体和动物中微小RNA变化与原颗粒蛋白途径之间的联系,假设其具有神经保护和神经康复作用。还发现原颗粒蛋白在缺氧条件下的神经保护过程以及启动神经康复过程中起着重要作用。这些特性可用于治疗,例如,通过提高原颗粒蛋白水平从而提高脑内原颗粒蛋白水平的药物,以期改善癫痫持续状态后的预后。